Cambridge scientists test world-first AI-designed vaccine

Researchers at Cambridge have conducted the first human trial of a vaccine whose design was generated entirely by artificial intelligence, a milestone that could dramatically accelerate how new vaccines are developed. The AI system was used to identify and optimise the vaccine's molecular targets, a process that traditionally takes years of laboratory work. Full trial results have not yet been published.